SFI
TECX

Susquehanna Fundamental Investments’s Tectonic Therapeutic TECX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,736
Closed -$44K – 1530
2022
Q3 		$44K Buy
+5,736
New +$63.7K ﹤0.01% 1376
2022
Q1 		$122K Buy
7,691
+4,991
+185% +$103K ﹤0.01% 1439
2021
Q4 		$125K Buy
+2,700
New +$155K ﹤0.01% 1313
2021
Q3 		– Sell
-2,028
Closed -$216K – 1932
2021
Q2 		$216K Buy
+2,028
New +$240K ﹤0.01% 1463

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna Fundamental Investments's TECX Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Tectonic Therapeutic (TECX) in Q4 2022, closing a stake of 5,736 shares — an estimated $44K sold.

Susquehanna Fundamental Investments first reported a position in TECX in Q2 2021 and held it in 4 quarters. The position peaked at $216K in Q2 2021. 45 funds tracked by Wall St. Rank hold TECX as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining Tectonic Therapeutic position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 5,736 Tectonic Therapeutic shares in Q4 2022, an estimated $44K.
  • Susquehanna Fundamental Investments first reported a position in Tectonic Therapeutic in Q2 2021 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's Tectonic Therapeutic position peaked at $216K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.